Immediate DAA treatment, syringe services, and society advocacy are key to eliminating the hepatitis C virus (HCV) among people who use drugs. Eliminating hepatitis C infections and preventing ...
Ambient AI and analytics may ease clinical workloads and uncover insights, but safety, validated data, HIPAA compliance, and equity must guide adoption.
No signs of conditions that may require surgery, such as urinary obstruction or abscess ...
Bronchiectasis appears to share genetic signals with chronic obstructive pulmonary disease (COPD), asthma, and chronic bronchitis, and a cross-ancestry genetic analysis of more than 1.8 million people ...
A real-world trial found 42.6% of patients with severe hand eczema cleared on oral alitretinoin. Chronic hand eczema (CHE) is a debilitating dermatologic condition that often proves refractory to ...
AMCP Nexus 2026 brings managed care leaders to San Diego October 26-29 to tackle Medicare negotiation, drug pricing policy, AI, and patient access. When managed care leaders convene in San Diego ...
The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential. Bepirovirsen is specifically approved for patients ...
Artificial intelligence (AI) dominated conversations at the American Academy of Ophthalmology (AAO) 2026 annual meeting, ...
Clinicians are voicing growing frustration over electronic medical record (EMR) inboxes, insurance peer-to-peer calls, and ...
The study found that most surveyed individuals with obesity support lower-cost options for weight maintenance, which could ...
An international eDelphi panel of 62 dermatologists agreed on a 2-step algorithm for tapering psoriasis biologics. Dose ...
Birth centers are unavailable in 10 states, and 39% of birth center births are self-pay, as licensing and Medicaid pay limit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results